T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta
- PMID: 3497030
- PMCID: PMC553535
- DOI: 10.1002/j.1460-2075.1987.tb02411.x
T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta
Abstract
T cell suppressor factor produced by human glioblastoma cells inhibits T cell proliferation in vitro and more specifically interferes with interleukin-2 (IL-2)-dependent T cell growth. Here we report the purification of this factor from conditioned medium of the human glioblastoma cell line 308. Amino-terminal sequence analysis of the 12.5-kd protein demonstrates that eight out of the first 20 amino acids are identical to human transforming growth factor-beta. Purified glioblastoma-derived T cell suppressor factor and transforming growth factor-beta from porcine platelets inhibit both IL-2-induced proliferation of ovalbumin-specific T helper cells and lectin-induced thymocyte proliferation with similar specific activities. If released by glioblastoma cells in vivo, the factor may contribute to impaired immunosurveillance and to the cellular immunodeficiency state detected in the patients.
Similar articles
-
Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family.EMBO J. 1987 Dec 1;6(12):3673-7. doi: 10.1002/j.1460-2075.1987.tb02700.x. EMBO J. 1987. PMID: 3322813 Free PMC article.
-
The glioblastoma-derived T cell suppressor factor/transforming growth factor-beta 2 inhibits T cell growth without affecting the interaction of interleukin 2 with its receptor.Eur J Immunol. 1988 Apr;18(4):593-600. doi: 10.1002/eji.1830180416. Eur J Immunol. 1988. PMID: 2452745
-
Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2.J Immunol. 1989 Nov 15;143(10):3222-9. J Immunol. 1989. PMID: 2809198
-
Glioblastoma-cell-derived T-cell suppressor factor (G-TsF). Sequence analysis and biologic mechanism of G-TsF.Ann N Y Acad Sci. 1988;540:437-9. doi: 10.1111/j.1749-6632.1988.tb27126.x. Ann N Y Acad Sci. 1988. PMID: 3264676 No abstract available.
-
Expression of TGF-beta 2 in human glioblastoma: a role in resistance to immune rejection?Ciba Found Symp. 1991;157:232-8; discussion 238-41. doi: 10.1002/9780470514061.ch15. Ciba Found Symp. 1991. PMID: 1649035 Review.
Cited by
-
Treatment of recurrent malignant glioma by repeated intracerebral injections of human recombinant interleukin-2 alone or in combination with systemic interferon-alpha. Results of a phase I clinical trial.J Neurooncol. 1992 Jan;12(1):75-83. doi: 10.1007/BF00172459. J Neurooncol. 1992. PMID: 1541981 Clinical Trial.
-
Transforming growth factor beta regulates thyroid growth. Role in the pathogenesis of nontoxic goiter.J Clin Invest. 1989 Mar;83(3):764-70. doi: 10.1172/JCI113955. J Clin Invest. 1989. PMID: 2921318 Free PMC article.
-
Suppression of high affinity IL-2 receptors on mitogen activated lymphocytes by glioma-derived suppressor factor.J Neurooncol. 1992 Sep;14(1):1-7. doi: 10.1007/BF00170940. J Neurooncol. 1992. PMID: 1335042
-
Immune-mediated encephalitis: on the role of antigen-presenting cells in brain tissue.Immunol Rev. 1987 Dec;100(1):185-201. doi: 10.1111/j.1600-065x.1987.tb00532.x. Immunol Rev. 1987. PMID: 3326820 Free PMC article. Review. No abstract available.
-
Characterization and purification of an immunosuppressive factor produced by a small cell lung cancer cell line.Jpn J Cancer Res. 1991 Mar;82(3):332-8. doi: 10.1111/j.1349-7006.1991.tb01850.x. Jpn J Cancer Res. 1991. PMID: 1850726 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources